Telehealth Ketamine in South Carolina: Access, Laws, and What to Know

Telehealth ketamine in South Carolina is legal and available statewide under federal telemedicine rules and the South Carolina Board of Medical Examiners, the state agency that licenses and regulates physicians in South Carolina. Prescribers must also follow the Ryan Haight Online Pharmacy Consumer Protection Act, a federal law enforced by the Drug Enforcement Administration that generally requires a valid provider-patient relationship, often established through a real-time video evaluation, before a controlled substance like ketamine can be prescribed remotely. Ketamine is a Schedule III controlled substance under the Controlled Substances Act, meaning it has a recognized medical use along with a moderate potential for misuse. South Carolina's mix of urban centers and underserved rural counties makes telehealth an important access point for treatment-resistant depression care, since in-person psychiatric specialists are scarce outside Charleston, Columbia, and Greenville.

South Carolina regulates telehealth through the South Carolina Telemedicine Act and Board of Medical Examiners rules, which allow physicians to establish a provider-patient relationship and prescribe medication entirely through remote encounters. The South Carolina Board of Pharmacy regulates the dispensing and compounding pharmacies that fill ketamine prescriptions. Prescribers must check the state's Prescription Monitoring Program before prescribing ketamine, and federal DEA telehealth rules for controlled substances apply on top of state requirements. South Carolina also participates in the Interstate Medical Licensure Compact, an agreement among member states that speeds license approval for physicians already licensed elsewhere in the compact, which expands the pool of telehealth providers available to state residents. Because federal rulemaking on telehealth prescribing is still evolving, confirm current requirements with the South Carolina Board of Medical Examiners before starting care. For a broader comparison of how these rules vary by state, see our guide to state ketamine telehealth regulations.

Provider availability for telehealth ketamine in South Carolina is moderate. National telehealth platforms serve the state, and the Interstate Medical Licensure Compact helps attract out-of-state physicians. Charleston, Columbia, and Greenville have the strongest in-person and telehealth options, while rural areas, particularly the Pee Dee region and Lowcountry counties, have far fewer local psychiatric providers. South Carolina ranks among the states with the lowest number of psychiatrists per capita, which adds to wait times for treatment-resistant depression care. South Carolina nurse practitioners must operate under a written practice agreement with a supervising physician to prescribe Schedule III controlled substances, so the clinician on a telehealth visit may be a physician, a supervised nurse practitioner, or, depending on scope-of-practice rules, a physician assistant. Our guide to choosing a ketamine provider covers what to check before booking an evaluation.

South Carolina compounding pharmacies are regulated by the state Board of Pharmacy, which enforces standards set by the United States Pharmacopeia (USP), the organization that publishes quality and purity standards for compounded medications. Both in-state pharmacies and properly licensed out-of-state compounding pharmacies can ship ketamine formulations, including sublingual troches and rapid-dissolve tablets, to South Carolina patients. The state's East Coast location generally allows for quick shipping from regional and national compounding pharmacies.

Insurance coverage for off-label ketamine therapy in South Carolina is limited, matching the national pattern described in our insurance versus cash-pay ketamine guide. Most private insurers do not cover compounded oral, sublingual, or IM ketamine prescribed off-label for psychiatric conditions. South Carolina Healthy Connections Medicaid, administered by the South Carolina Department of Health and Human Services, may cover Spravato (esketamine) with prior authorization for documented treatment-resistant depression, but it does not typically cover off-label ketamine. Commercial insurance coverage for Spravato is more likely when a patient meets treatment-resistant depression criteria. Typical self-pay costs in South Carolina range from about $175 to $450 for an initial evaluation and $75 to $250 per month for ongoing treatment, though exact pricing depends on the provider and formulation. Patients without insurance should ask providers directly about payment plans and financial assistance; our guide to ketamine cost and payment breaks down what drives those numbers.

Several South Carolina-specific factors affect how patients start and continue telehealth ketamine treatment. Our guides on how to get a ketamine prescription online and safe at-home ketamine use cover the practical side of remote treatment in more detail.